BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34
BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34
BMO Capital將Chemours上調至跑贏大盤,將目標股價上調至34美元
BMO Capital analyst John McNulty upgrades Chemours (NYSE:CC) from Market Perform to Outperform and raises the price target from $19 to $34.
BMO Capital分析師約翰·麥克納爾蒂將Chemours(紐約證券交易所代碼:CC)從市場表現上調至跑贏大盤,並將目標股價從19美元上調至34美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。